Gsa Capital Partners LLP Pmv Pharmaceuticals, Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 73,352 shares of PMVP stock, worth $107,827. This represents 0.01% of its overall portfolio holdings.
Number of Shares
73,352
Previous 77,743
5.65%
Holding current value
$107,827
Previous $126,000
13.49%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding PMVP
# of Institutions
83Shares Held
41.9MCall Options Held
3.1KPut Options Held
1.7K-
Orbimed Advisors LLC San Diego, CA6.48MShares$9.52 Million0.23% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.65MShares$5.36 Million0.08% of portfolio
-
Sio Capital Management, LLC New York, NY3.21MShares$4.72 Million2.53% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.86 Million0.43% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.45 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $67.1M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...